CRISPR/Cas9 nickase-mediated inactivation of hepatitis B virus replication

被引：0
|
作者：
Karimova, M. [1 ]
Beschorner, N. [1 ]
Dammermann, W. [2 ]
Chemnitz, J. [1 ]
Indenbirken, D. [1 ]
Grundhoff, A. [1 ,3 ]
Lueth, S. [2 ]
Buchholz, F. [4 ,5 ]
zur Wiesch, J. Schulze [6 ]
Hauber, J. [1 ]
机构：
[1] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf 1, Inst Expt Immunol & Hepatol, Dept Med, Hamburg, Germany
[3] German Ctr Infect Res DZIF, Hamburg, Germany
[4] Univ Hosp, Dept Med Syst Biol, Dresden, Germany
[5] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany
[6] Univ Med Ctr Hamburg Eppendorf 1, Dept Med, Hamburg, Germany
来源：
JOURNAL OF VIRAL HEPATITIS | 2015年 / 22卷
关键词：
D O I：
10.1111/jvh.23_12425
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P025
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] CRISPR/Cas9
    Mizuno, Naoaki
    Mizutani, Eiji
    Sato, Hideyuki
    Kasai, Mariko
    Nakauchi, Hiromitsu
    Yamaguchi, Tomoyuki
    BIO-PROTOCOL, 2019, 9 (13):
  • [42] Development of CRISPR/Cas9 mediated virus resistance in agriculturally important crops
    Khatodia, Surender
    Bhatotia, Kirti
    Tuteja, Narendra
    BIOENGINEERED, 2017, 8 (03) : 274 - 279
  • [43] The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
    Lv, Wei
    Li, Tao
    Wang, Shanshan
    Wang, Huihui
    Li, Xuemei
    Zhang, Shubing
    Wang, Lianzi
    Xu, Yuanhong
    Wei, Wei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [44] Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and Fokl-dCas9
    Terao, Miho
    Tamano, Moe
    Hara, Satoshi
    Kato, Tomoko
    Kinoshita, Masato
    Takada, Shuji
    EXPERIMENTAL ANIMALS, 2016, 65 (03) : 275 - 283
  • [45] CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse
    Zhu, Wei
    Xie, Kun
    Xu, Yuanjian
    Wang, Le
    Chen, Kaiming
    Zhang, Longzhen
    Fang, Jianmin
    VIRUS RESEARCH, 2016, 217 : 125 - 132
  • [46] SiRNA and CRISPR/Cas9 Mediated Knockout of αENAC
    Tagalakis, Aristides
    van Haasteren, Joost
    Aldossary, Ahmad
    Rosa, Luca
    Munye, Mustafa
    McCarthy, David
    Hart, Stephen
    MOLECULAR THERAPY, 2016, 24 : S11 - S11
  • [47] CRISPR/Cas9 mediated genome engineering in Drosophila
    Bassett, Andrew
    Liu, Ji-Long
    METHODS, 2014, 69 (02) : 128 - 136
  • [48] Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
    Liu, Xing
    Hao, Ruidong
    Chen, Shuliang
    Guo, Deyin
    Chen, Yu
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 2252 - 2261
  • [49] Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9
    Fu, Becky Xu Hua
    Smith, Justin D.
    Fuchs, Ryan T.
    Mabuchis, Megumu
    Curcuru, Jennifer
    Robb, G. Brett
    Fire, Andrew Z.
    NATURE MICROBIOLOGY, 2019, 4 (05) : 888 - 897
  • [50] An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation
    Li, Hao
    Sheng, Chunyu
    Liu, Hongbo
    Liu, Guangze
    Du, Xinying
    Du, Juan
    Zhan, Linsheng
    Li, Peng
    Yang, Chaojie
    Qi, Lihua
    Wang, Jian
    Yang, Xiaoxia
    Jia, Leili
    Xie, Jing
    Wang, Ligui
    Hao, Rongzhang
    Xu, Dongping
    Tong, Yigang
    Zhou, Yusen
    Zhou, Jianjun
    Sun, Yansong
    Li, Qiao
    Qiu, Shaofu
    Song, Hongbin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (09): : 1104 - 1113
12345